AI assistant
Enprise Group Limited — Director's Dealing 2021
Mar 1, 2021
66187_rns_2021-03-02_fb67231e-1592-4bb3-9722-61bf0af4992f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [86 x 23] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:
| Enprise GroupLimited | |
|---|---|
| 1-Mar-21 | |
| 23-Oct-20 | |
| Lindsay John Phillips | |
| Enprise GroupLimited | |
| Director | |
| s) | |
| Ordinary Shares | |
| RightsIssue | |
| 2,826,360 | |
| 3,032,637 | |
| No Change | |
| Nightingale Partners Pty Limited | 3,032,637 |
| To NZX Limited; and | To NZX Limited; and | To NZX Limited; and |
|---|---|---|
| Name of listed issuer: | Enprise GroupLimited | |
| Date this disclosure made: | 1-Mar-21 | |
| Date of last disclosure: | 23-Oct-20 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Lindsay John Phillips | |
| Name of listed issuer: | Enprise GroupLimited | |
| Name of related body corporate (if applicable): | ||
| Position held in listed issuer: | Director | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivative | s) | |
| Class of affectedquoted financialproducts: | Ordinary Shares | |
| Nature of the affected relevant interest(s): | RightsIssue | |
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 2,826,360 | |
| Number held in class after acquisition or disposal: | 3,032,637 | |
| Current registered holder(s): | No Change | |
| Registered holder(s)once transfers are registered: | Nightingale Partners Pty Limited | 3,032,637 |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| Type of affected derivative: | ||
|---|---|---|
| Class of underlyingfinancialproducts: | ||
| Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): A statement as to whether the derivative is cash settled orphysicallysettled: |
||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expiry date ofthe derivative(ifany): | ||
| The price specifiedinthe terms ofthe derivative (ifany): | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
||
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | 2 | |
| 1-Mar-21 | ||
| Acquired Shares off market | ||
| gs Ltd and Dr Stephanie Phillips |
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
$214,528 | |
|---|---|---|
| Numberof financialproducts towhichthe transaction related: | 206,277 | |
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | N/A | |
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: |
||
| Date of theprior written clearance(if any): |
Summary of other relevant interests after acquisition or disposal:
| Ordinary Shares | ||
|---|---|---|
| Benefical | ||
| 3,032,637 | ||
| As above | ||
| Type ofderivative: | ||
| Details of derivative,- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice's specified terms(if any): | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
||
| For that derivative relevant interest,- | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 1-Mar-21 Name and title of authorised person: Elliot Cooper - CEO
==> picture [317 x 163] intentionally omitted <==
Notes
Use this form to disclose all the acquisitions and disposals by a director or senior manager of a listed issuer, or of a related body corporate, or in specified derivatives. The disclosure must be made within—
(a) 20 working days after the first acquisition or disposal disclosed in this notice if the acquisitions or disposals are of a kind referred to in section 297(2)(a) of the Financial Markets Conduct Act 2013; or
(b) in any other case, 5 trading days after the first acquisition or disposal disclosed in this notice.